Table 2 Relationship between β3GNT2 expression and clinicopathological features of ESCA patients
From: Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma
Clinicopathological features | Number of patients | β3GNT2 expression | P-value | |
|---|---|---|---|---|
Low (n = 32) | High (n = 33) | |||
Age | ||||
≤ 60 | 30 | 16 | 14 | 0.418 |
> 60 | 35 | 16 | 19 | |
Gender | ||||
Male | 35 | 15 | 20 | 0.154 |
Female | 30 | 17 | 13 | |
Lymph node metastasis | ||||
Positive | 31 | 14 | 17 | 0.052 |
Negative | 34 | 18 | 16 | |
Tumor size (cm) | ||||
< 5 | 37 | 23 | 14 | 0.036 |
≥ 5 | 28 | 9 | 19 | |
TNM stage | ||||
I + II | 35 | 20 | 15 | 0.017 |
III + IV | 30 | 12 | 18 | |